Ayroldi E, Cannarile L, D'Adamio F, Riccardi C
Department of Clinical Medicine, Pathology and Pharmacology, Perugia University Medical School, Italy.
Immunology. 1995 Apr;84(4):528-35.
Experiments were performed to evaluate the role of antigen-presenting cells (APC) and the effect of interleukin-4 (IL-4) and glucocorticoid hormone (GCH) exposure on the in vitro deletion of CD4+ CD8- and CD8+ CD4- T cells by staphylococcal enterotoxin B (SEB). APC fixation with the chemical cross-linker 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (ECDI) inhibited their capacity to induce SEB-specific deletion of mature T lymphocytes. Deletion was not influenced by treatment with anti-CD28 antibodies, which modulate T-cell activation. However, it was augmented by IL-4, known to counteract anti-CD3- and GCH-induced thymocyte apoptosis, and was inhibited by dexamethasone (DEX). These results indicate that metabolically active APC are required for deletion of antigen-specific mature T cells and suggest that IL-4 and GCH can modulate this phenomenon in vitro.
进行实验以评估抗原呈递细胞(APC)的作用以及白细胞介素-4(IL-4)和糖皮质激素(GCH)暴露对葡萄球菌肠毒素B(SEB)体外清除CD4 + CD8-和CD8 + CD4- T细胞的影响。用化学交联剂1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(ECDI)固定APC会抑制其诱导成熟T淋巴细胞SEB特异性清除的能力。用抗CD28抗体处理不影响清除,抗CD28抗体可调节T细胞活化。然而,已知可抵消抗CD3和GCH诱导的胸腺细胞凋亡的IL-4可增强清除作用,而地塞米松(DEX)则抑制清除作用。这些结果表明,代谢活跃的APC是清除抗原特异性成熟T细胞所必需的,并表明IL-4和GCH可在体外调节这一现象。